Premium
Cardiac amyloidosis in non‐transplant cardiac surgery
Author(s) -
Smith Alex,
Balmforth D.,
Treibel T. A.,
Lall Kulvinder,
Oo Aung,
Ambekar Shirish
Publication year - 2021
Publication title -
journal of cardiac surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.428
H-Index - 58
eISSN - 1540-8191
pISSN - 0886-0440
DOI - 10.1111/jocs.15629
Subject(s) - medicine , cardiac amyloidosis , amyloidosis , transthyretin , cardiac surgery , restrictive cardiomyopathy , complication , cardiomyopathy , stenosis , cardiology , cardiac valve , surgery , intensive care medicine , radiology , heart failure
Cardiac amyloidosis is a rare infiltrative cardiomyopathy that portends a poor prognosis. There is a growing recognition of co‐existent aortic valve stenosis and transthyretin cardiac amyloidosis, with some studies suggesting that dual pathology may be associated increased risk of complication and mortality during surgical intervention. This review aims to evaluate the available literature on non‐transplant cardiac surgical interventions in patients with cardiac amyloidosis, with particular focus on diagnosis, high surgical risk and areas of uncertainty that require further research.